Recombinant human monoclonal antibody to FCGRT/FCRN.
Applications
ELISA, FACS, Functional Assay, In Vivo
Reactivity
Human
Host
Human
Clonality
Monoclonal
Isotype
IgG1
Light Chains
kappa
Conjugate
Unconjugated
Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Molecular Weight
This antibody has a predicted MW of 144.6 kDa.
Purity
> 92.74% (by SDS-PAGE and SEC-HPLC).
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
SDS-PAGE analysis of Orilanolimab Biosimilar - Anti-FCGRT/FCRN Antibody - Low endotoxin, Azide free (A323637) under reducing (R) conditions confirms that the purity of this antibody is greater than 95%.
SEC-HPLC analysis of Orilanolimab Biosimilar - Anti-FCGRT/FCRN Antibody - Low endotoxin, Azide free (A323637) confirms that the purity of this antibody is 92.74%.
Immobilized recombinant FcRn (FCGRT) (His tag) + FcRn (B2M) protein at 2 µg/ml is bound by Orilanolimab Biosimilar - Anti-FCGRT/FCRN Antibody - Low endotoxin, Azide free (A323637). EC50 = 0.0311 µg/ml.
Publishing research using Orilanolimab Biosimilar - Anti-FCGRT/FCRN Antibody - Low endotoxin, Azide free (A323637)? Please let us know so that we can list the citation on this page.
